An increasing number of studies indicate that the gut microbiota interacts with host genetics, drugs, hormones, food nutrients, and other environmental factors, which may affect carcinogenesis, immunological function, glycolipid metabolism, and cognition. Gut microbiota dysbiosis may affect metabolic pathways, resulting in metabolic disorders, such as obesity, metabolic syndrome (MS), dyslipidemia/hyperlipidemia, type 2 diabetes mellitus (T2DM), and non-alcoholic fatty liver disease (NAFLD). Many studies have found that prebiotics, probiotics, and postbiotics have a variety of beneficial potentials for improving glycolipid metabolism, inflammation, and associated metabolic disorders.
The majority of these studies have demonstrated their positive benefits through the involvement in gut microbiota modulation. However, the key components in probiotics, prebiotics, and postbiotics regulating intestinal microbiota are still unclear. Thus, there is great interest in identifying the significant chemicals and elucidating the interactions between probiotics, prebiotics, postbiotics, and gut microbiota in glycolipid metabolism, inflammation, and associated metabolic disorders, which will help to rational design the dietary approaches to improve human health via an intentional modulation of gut microbiota.
This Research Topic welcomes and encourages the Original Research articles, Reviews, and Mini-Reviews that cover but are not limited to the following sub-topics:
1) Roles of prebiotics, probiotics, postbiotics, and functional components in improving glycolipid metabolic disorders
2) Advances in the application of prebiotics, probiotics, and postbiotics in the food matrix.
An increasing number of studies indicate that the gut microbiota interacts with host genetics, drugs, hormones, food nutrients, and other environmental factors, which may affect carcinogenesis, immunological function, glycolipid metabolism, and cognition. Gut microbiota dysbiosis may affect metabolic pathways, resulting in metabolic disorders, such as obesity, metabolic syndrome (MS), dyslipidemia/hyperlipidemia, type 2 diabetes mellitus (T2DM), and non-alcoholic fatty liver disease (NAFLD). Many studies have found that prebiotics, probiotics, and postbiotics have a variety of beneficial potentials for improving glycolipid metabolism, inflammation, and associated metabolic disorders.
The majority of these studies have demonstrated their positive benefits through the involvement in gut microbiota modulation. However, the key components in probiotics, prebiotics, and postbiotics regulating intestinal microbiota are still unclear. Thus, there is great interest in identifying the significant chemicals and elucidating the interactions between probiotics, prebiotics, postbiotics, and gut microbiota in glycolipid metabolism, inflammation, and associated metabolic disorders, which will help to rational design the dietary approaches to improve human health via an intentional modulation of gut microbiota.
This Research Topic welcomes and encourages the Original Research articles, Reviews, and Mini-Reviews that cover but are not limited to the following sub-topics:
1) Roles of prebiotics, probiotics, postbiotics, and functional components in improving glycolipid metabolic disorders
2) Advances in the application of prebiotics, probiotics, and postbiotics in the food matrix.
